Questions? Feedback? powered by Olark live chat software
All Site

Upcoming Events & Conferences

On Demand Webinars

ATCC Advancing Authentication: A Case for Credibility in Science


Nothing can hinder the integrity of research efforts like contamination or misidentification. Explore the real-life effects when research materials are not authenticated and the steps we can take to establish best practices in the laboratory.

 

Tools for Every Stage of Your Preclinical Drug Development Workstream Webinar

ATCC Webinar Toxicology crop

Cell‑based toxicity studies need many physiologically relevant cells. Telomerase‑immortalized primary cells grow like continuous lines while retaining natural functions. This webinar highlights ATCC respiratory, skin, and kidney models and shows data proving these cells deliver tissue‑relevant, reproducible results for toxicology and other assays.

 

 ATCC Organoid Growth Kits

Organoids are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research. These 3-D models are becoming more relevant because they are predictive of the in vivo tumor microenvironment. In efforts to simplify Organoid culture, ATCC has developed Organoid Growth Kits which comprise single-use supplements created to streamline media preparation.

These kits contain the most costly and cumbersome supplements and reagents, reducing the time and effort required to prepare media and ensuring the successful growth of your organoids.

Differentiating iPSCs into Neural Cell Types and Organoids

iPSCs have transformed neural research by providing adaptable models for studying neurological disorders, development, and regenerative therapies. In this webinar, Dr. Dan Cortes of HHMI shares advanced methods for differentiating iPSCs into neural cell types and brain/cerebral organoids, addressing best practices, troubleshooting, reducing batch variability, enabling high‑throughput screening, and achieving high‑quality electrophysiology and calcium imaging in neurons and organoids.
Pluripotent Stem Cells to Beta Islet Cells - Advancing Translational Diabetes Research


Diabetes impacts over 500 million people globally, highlighting the urgent need for innovative therapies that can improve patient outcomes. Pluripotent stem cells (PSCs) offer remarkable potential in regenerative medicine by enabling the development of functional beta islet cell s- paving the way for transformative treatments for this widespread disease.

Revolutionising Bladder Cancer Care: How Multiplex Assays Are Changing the Game


Charles Rosser has developed Oncuria®, a bladder cancer test using Luminex® xMAP® Technology to detect 10 glycoproteins with 93% sensitivity and up to 95% specificity. It aids in early detection, monitoring, and predicting response to immunotherapy. Now available as a laboratory-developed test (LDT), Oncuria® has received FDA Breakthrough Device Designation, representing a major advance in bladder cancer care.

Methods and Reagents for Culturing and Characterizing Organoids and Cancer Spheroids


In this webinar, “Methods and Reagents for Culturing and Characterizing Organoids and Cancer Spheroids”, we demonstrate techniques to culture and perform high-throughput analysis of multiple organoid and cancer models.

Podcasts

ATCC podcast banner







ATCC | Behind the Biology

listen on



Click here to visit ATCC's podcast page: https://www.atcc.org/resources/podcasts